See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $457B | 7.5x | 17.5x | |
| $379B | 4.4x | 16.0x | |
| $249B | 4.8x | 19.9x | |
| $174B | 2.6x | 11.7x | |
| $90.3B | 1.7x | 8.0x | |
| $79.5B | 3.9x | 16.2x | |
| $67.2B | 3.5x | 12.6x | |
| $60.0B | 8.5x | 36.9x | |
| $56.7B | 3.7x | 15.0x | |
| $48.7B | 3.3x | 22.9x | |
| $45.6B | 8.7x | 37.5x | |
| $41.3B | 2.7x | 12.4x | |
| $41.1B | 4.3x | 17.6x | |
| $36.0B | 1.5x | 8.1x | |
| $31.1B | 2.5x | 17.0x | |
| $24.9B | 4.0x | 17.7x | |
| $23.5B | 2.0x | 11.6x | |
| $23.2B | 1.5x | 8.1x | |
| $21.5B | 2.1x | 5.9x | |
| $17.6B | 1.6x | 10.8x | |
| $13.0B | 7.8x | 38.0x | |
| $12.6B | 2.1x | 10.5x | |
| $12.4B | 2.1x | 14.0x | |
| $10.2B | 7.3x | 40.8x | |
| $10.1B | 6.6x | 26.5x | |
| $9.5B | 6.6x | 35.3x | |
| $8.6B | 1.4x | 8.0x | |
| $8.2B | 1.3x | 12.8x | |
| $7.0B | 7.0x | 27.1x | |
| $6.9B | 1.2x | 6.7x | |
| $6.1B | 9.3x | 29.0x | |
| $5.8B | 3.8x | 19.1x | |
| $5.6B | 1.9x | 12.7x | |
| $5.2B | 1.2x | 7.1x | |
| $4.4B | 1.5x | 6.5x | |
| $4.4B | 2.1x | 11.7x | |
| $4.2B | 10.0x | 30.6x | |
| $4.2B | 1.3x | 7.1x | |
| $4.1B | 8.5x | 33.2x | |
| $4.0B | 3.6x | 10.9x | |
| $3.8B | 1.2x | 7.5x | |
| $3.6B | 2.3x | 12.4x | |
| $3.5B | 1.7x | 10.0x | |
| $3.4B | 2.8x | 17.2x | |
| $3.2B | 0.9x | 5.9x | |
| $3.2B | 3.7x | 9.1x | |
| $3.2B | 2.2x | 10.6x | |
| $3.2B | 0.7x | 5.9x | |
| $3.1B | 9.4x | 35.0x | |
| $2.9B | 1.3x | 9.4x | |
| $2.7B | 1.1x | 5.7x | |
| $2.6B | 2.5x | 11.2x | |
| $2.6B | 1.0x | 7.7x | |
| $2.2B | 0.5x | 6.4x | |
| $2.2B | 5.8x | 16.8x | |
| $2.2B | 5.2x | 19.7x | |
| $2.2B | 2.9x | 14.7x | |
| $2.2B | 3.8x | 18.6x | |
| $2.1B | 0.9x | 7.0x | |
| $2.1B | 2.7x | 18.9x | |
| $2.1B | 1.2x | 10.5x | |
| $1.9B | 1.7x | 12.5x | |
| $1.9B | 2.8x | 13.0x | |
| $1.9B | 2.3x | 11.4x | |
| $1.8B | 0.9x | 7.4x | |
| $1.6B | 6.2x | 17.5x | |
| $1.6B | 1.3x | 8.6x | |
| $1.6B | n/a | n/a | |
| $1.5B | 0.7x | 8.1x | |
| $1.4B | 1.7x | 7.3x | |
| $1.3B | 0.6x | 5.8x | |
| $1.3B | 0.7x | 6.1x | |
| $1.1B | 2.7x | 12.3x | |
| $1.1B | 1.5x | 10.1x | |
| $1.0B | 0.9x | 8.5x | |
| $953M | 1.2x | 6.5x | |
| $938M | 7.5x | 28.1x | |
| $936M | 3.8x | 54.8x | |
| $908M | 2.0x | 9.5x | |
| $780M | 1.8x | 10.9x | |
| $737M | n/a | n/a | |
| $735M | 0.2x | 1.7x | |
| $726M | n/a | n/a | |
| $648M | n/a | n/a | |
| $592M | 0.8x | 6.6x | |
| $591M | 3.4x | 13.5x | |
| $556M | 0.4x | n/a | |
| $501M | 0.7x | 3.4x | |
| $490M | n/a | n/a | |
| $415M | 1.4x | -19.7x | |
| $408M | 1.5x | 18.6x | |
| $385M | 1.9x | -41.3x | |
| $375M | n/a | n/a | |
| $350M | 1.2x | 9.4x | |
| $338M | 6.5x | 24.9x | |
| $300M | n/a | n/a | |
| $288M | 0.7x | 8.0x | |
| $272M | n/a | n/a | |
| $245M | 1.7x | 7.3x | |
| $221M | 0.6x | 10.0x | |
| $201M | n/a | n/a | |
| $197M | 0.4x | 11.4x | |
| $194M | 2.3x | 13.7x | |
| $190M | 1.0x | 9.3x | |
| $173M | 0.8x | 3.7x | |
| $158M | 0.8x | 5.7x | |
| $139M | 0.6x | 5.6x | |
| $137M | 2.2x | 8.0x | |
| $132M | 0.5x | 6.0x | |
| $121M | n/a | n/a | |
| $84.3M | n/a | n/a | |
| $68.0M | 0.3x | 7.0x | |
| $61.3M | n/a | n/a | |
| $61.0M | 2.3x | 9.7x | |
| $43.2M | 0.9x | n/a | |
| $42.7M | n/a | n/a | |
| $41.0M | n/a | n/a | |
| $40.3M | n/a | n/a | |
| $27.6M | 2.2x | n/a | |
| $27.1M | n/a | n/a | |
| $25.0M | n/a | n/a | |
| $20.6M | 1.1x | -12.0x | |
| $19.2M | n/a | n/a | |
| $14.0M | n/a | n/a | |
| $8.5M | n/a | n/a | |
| $7.6M | n/a | n/a | |
| $5.6M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| -$35.5M | -0.1x | -59.2x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty